Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.
BT - International journal of mycobacteriology C1 -http://www.ncbi.nlm.nih.gov/pubmed/27242236?dopt=Abstract
DO - 10.1016/j.ijmyco.2016.02.002 IS - 2 J2 - Int J Mycobacteriol LA - eng N2 -Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.
PY - 2016 SP - 223 EP - 5 T2 - International journal of mycobacteriology TI - Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept. UR - http://www.sciencedirect.com/science/article/pii/S2212553116000212 VL - 5 SN - 2212-554X ER -